|
|
|
| Effect observation of laparoscopic im plantation of125I radioactive particles combined Gem citabine chemotherapy after surgery for advanced pancreatic cancer |
| ZHONG Zhen-wu1 ZHONG Hui2 LIU Ling1 XIE Ling-yan1 XU Shu-mei1 |
1.Department of General Surgery,People′s Hospital of Xingguo County,Jiangxi Province,Xingguo 342400,China;
2.The Third Department of Internal Medicine,People′s Hospital of Xingguo County,Jiangxi Province,Xingguo 342400,China |
|
|
|
|
Abstract ObjectiveTo observe the clinical effect of Gemcitabine chemotherapy in the treatment of advanced pancreatic cancer after laparoscopic implantation of125I radioactive particles.MethodsFrom May 2016 to May 2017,40 patients with advanced pancreatic cancer treated in our hospital were enrolled as the research object.With the consent of the patients,they were evenly divided into reference group and research group by drawing lots.In the reference group,Gemcitabine chemotherapy alone was used,while in the research group,laparoscopic implantation of125I radioactive particles followed by Gemcitabine chemotherapy was adopted.The diameters of tumor,jaundice index and body weight were compared between the two groups after treatment.The symptoms of abdominal pain and ascites,and nutritional status of the patients in both groups were observed and the improvement rates were compared.The occurrence of pancreatic fistula and hemorrhage was observed and recorded in the research group and the safety of the operation was summarized.ResultsAfter treatment,the tumor diameter of the research group was significantly smaller than that of the reference group.The jaundice index was significantly lower,and the weight gain increased obviously compared with those in the reference group.In the research group,the improvement rates of abdominal pain,ascites and nutritional status were higher than those in the reference group.The indexes mentioned above were displayed statistical significance between the two groups(P<0.05).The incidence of relevant complications in the research group was 10.00%,which was not significantly different from that in the reference group accounting for 0.00%(P＞0.05).ConclusionAfter laparoscopic implantation of125I radioactive paticles,combination of Gemcitabine chemotherapy in patients with advanced pancreatic cancer can effectively reduce tumor size,decrease jaundice index,relieve the symptoms of abdominal pain and ascites,improve the nutritional status,and help patient to gain weight as well as improve quality of life.In addition,the incidence of relevant complications after particle implantation is low,the combined therapy is safe and effective for the treatment of advanced pancreatic cancer and is worth promoting.
|
|
|
|
|
|
| [1] |
师光永.CT引导下125I粒子植入联合药物化疗治疗晚期局部胰腺癌临床评价[J].中国药业，2017，26（14）：50-53.
|
| [2] |
平娟，孟涛，王保全，等.Nab-P联合吉西他滨与吉西他滨单药治疗晚期胰腺癌的疗效观察及不良反应分析[J].基因组学与应用生物学，2016，35（9）：2275-2279.
|
| [3] |
陈光新.吉西他滨联合顺铂对晚期胰腺癌的疗效分析[J].中国现代普通外科进展，2015，18（9）：730-732.
|
| [4] |
梁英林.放射治疗联合药物化疗治疗局部晚期胰腺癌的临床分析[J].海峡药学，2017，29（6）：198-199.
|
| [5] |
李士猛.吉西他滨联合替吉奥序贯替吉奥同步放化疗与联合化疗治疗局部晚期胰腺癌比较观察[J].肿瘤基础与临床，2016，29（3）：216-221.
|
| [6] |
郑伟，康静波，温居一，等.不同方案化疗联合立体定向放疗治疗老年晚期胰腺癌的临床研究[J].中国医药，2016，11（11）：1657-1661.
|
| [7] |
胜照杰，孙静.立体定向放疗联合吉西他滨治疗局部晚期胰腺癌[J].肿瘤基础与临床，2016，29（3）：213-215.
|
| [8] |
杨丽丽.尼妥珠单抗与吉西他滨联合顺铂化疗方案在晚期胰腺癌治疗中的应用[J].河南医学研究，2017，26（15）：2766-2767.
|
| [9] |
陈剑波，朱海生，董卫华，等.吉西他滨单药及联合奥沙利铂治疗晚期胰腺癌的临床疗效[J].广西医科大学学报，2015，32（3）：497-499.
|
| [10] |
曹敬毅，王淇超，王乾，等.125I放射性粒子植入联合低剂量调强适形放疗及内分泌治疗在中晚期前列腺癌中的临床疗效评价[J].国际泌尿系统杂志，2015，35（3）：324-327.
|
| [11] |
林丽洲，宛新建.一种治疗胰胆管恶性肿瘤的新型放射性支架的可行性研究[J].中华消化内镜杂志，2015，32（10）：678-681.
|
| [12] |
姜远才，崔凤.CT导向下I125粒子植入治疗椎旁转移瘤的临床疗效[J].浙江创伤外科，2016，21（6）：1181-1182.
|
| [13] |
郑丹，袁志平，林川，等.I125粒子植入治疗手术和放化疗后复发转移直肠癌的疗效探析[J].深圳中西医结合杂志，2015，25（22）：6-7.
|
| [14] |
陈玉峰.125I粒子植入联合中医中药治疗肺癌近期疗效的CT 评价[J].中国卫生产业，2015，12（30）：138-140.
|
| [15] |
张小玉，吴超群，代洪玉，等.放射性粒子植入联合锶～（89）治疗转移性椎体肿瘤的疗效分析[J].四川医学，2015，36（12）：1667-1670.
|
|
|
|
